Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 4 | +263K | 100% | $14.43 | +$3.79M |
Sells | 0 | ||||
Net | +4 | +263K | 100% | +$3.79M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Mark Lappe | Chief Executive Officer, Director | $15.9M | +$2.42M | +18% | Sep 12, 2024 |
Jon Faiz Kayyem | Director | $14.1M | Jun 24, 2024 | ||
Brendan P. Eckelman | Chief Scientific Officer | $6.13M | May 29, 2024 | ||
Douglas Forsyth | Director | $3.16M | +$1.04M | +48.9% | Aug 22, 2024 |
Viking Global Investors Lp | 10%+ Owner | $1.65M | May 29, 2024 | ||
Kristiina Vuori | Director | $208K | +$200K | +2613% | Sep 10, 2024 |
Kimberly Manhard | Director | $140K | +$140K | Aug 28, 2024 | |
Kelly Deck | Chief Financial Officer | May 30, 2024 | |||
Inhibrx, Inc. | 10%+ Owner | May 29, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|